Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction

Packer, Milton; D. Anker, Stefan; Butler, Javed; Filippatos, Gerasimos; Pedro Ferreira, João; Pocock, Stuart; E. Carson, Peter; S. Anand, Inder; Doehner, Wolfram; Haass, Markus; Komajda, Michel; B. Miller, Alan; Pehrson, Steen; R. Teerlink, John; Brueckmann, Martina; Jamal, Waheed; Zeller, Cordula; Schnaidt, Sven; Zannad, Faı̈ez

doi:10.1161/circulationaha.120.051783

Public

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction

Published in Circulation • Oct 21, 2020

Authors:

Milton Packer

Stefan D. Anker

Javed Butler

Abstract

Background: Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, with or without diabetes, but additional data are needed about the effect of the drug on inpatient and outpatient events that reflec...

Subject

Empagliflozin

Medicine

Heart failure

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!